ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 100 filers reported holding ATHIRA PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $41,025 | -19.5% | 16,410 | +2.0% | 0.00% | – |
| Q4 2022 | $50,983 | +6.2% | 16,083 | -0.4% | 0.00% | – |
| Q3 2022 | $48,000 | -2.0% | 16,141 | +1.4% | 0.00% | – |
| Q2 2022 | $49,000 | -77.3% | 15,913 | -0.6% | 0.00% | -100.0% |
| Q1 2022 | $216,000 | -3.1% | 16,012 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $223,000 | +34.3% | 17,139 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $166,000 | -10.3% | 17,652 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $185,000 | +24.2% | 18,072 | +123.4% | 0.00% | 0.0% |
| Q1 2021 | $149,000 | -41.8% | 8,089 | +8.3% | 0.00% | 0.0% |
| Q4 2020 | $256,000 | – | 7,469 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 230,000 | $351,351 | 0.48% |
| Perceptive Advisors | 4,797,278 | $14,632,000 | 0.46% |
| Ikarian Capital, LLC | 784,200 | $2,393,000 | 0.44% |
| Bristlecone Advisors, LLC | 700,926 | $2,138,000 | 0.26% |
| Altium Capital Management LP | 200,100 | $610,000 | 0.24% |
| RA Capital Management | 1,878,000 | $5,728,000 | 0.15% |
| Logos Global Management LP | 220,000 | $671,000 | 0.12% |
| PATHSTONE FAMILY OFFICE, LLC | 1,688,840 | $5,150,963 | 0.11% |
| Ikarian Capital, LLC | 199,500 | $609,000 | 0.11% |
| SG3 Management, LLC | 206,000 | $628,000 | 0.07% |